Company Search:
Advanced Search
Sponsored Links
Zhejiang Hisun Pharmaceutical, Ltd. Company Snapshot
Zhejiang Hisun Pharmaceutical, Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisun Pharmaceutical, Ltd. with three other companies in this sector in China: Xin Jiang Ready Health Industry Co Ltd (2016 sales of 9.00 billion Chinese Renmimbi [US$1.40 billion] of which 86% was Pharmaceutical - Wholesale), Joincare Pharmaceutical Group Industry Company Limited (9.72 billion Chinese Renmimbi [US$1.52 billion] of which 99% was Industry and Commerce), and Shanghai Shyndec Pharmaceutical Co Ltd (9.12 billion Chinese Renmimbi [US$1.42 billion] of which 49% was Drug Products).

Sales Analysis. Zhejiang Hisun Pharmaceutical, Ltd. reported sales of 9.73 billion Chinese Renmimbi (US$1.52 billion) for the year ending December of 2016. This represents an increase of 11.0% versus 2015, when the company's sales were 8.77 billion Chinese Renmimbi. Despite this increase, sales are still below the level achieved in 2014, when Zhejiang Hisun Pharmaceutical, Ltd. reported sales of 10.10 billion Chinese Renmimbi. Sales of Drug/medicine Sales saw an increase of 11.4% in 2016, from 5.62 billion Chinese Renmimbi to 6.26 billion Chinese Renmimbi. Not all segments of Zhejiang Hisun Pharmaceutical, Ltd. experienced an increase in sales in 2016: sales of Other, Main Operations fell 98.1% to 6,837.61 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zhejiang Hisun Pharmaceutical, Ltd.
  Stock Performance Chart for Zhejiang Hisun Pharmaceutical, Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 15.75
(Figures in Chinese Renmimbi)
1 Week 5.2%   13 Weeks 8.5%  
4 Weeks 21.2%   52 Weeks 16.2%  
Zhejiang Hisun Pharmaceutical, Ltd. Key Data:
  Ticker: 600267 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 9,732,995,783
(Year Ending Jan 2017).
Employees: 9,441
  Currency: Chinese Renmimbi Market Cap: 15,207,126,512
  Fiscal Yr Ends: December Shares Outstanding: 965,531,842
  Share Type: A Gu Closely Held Shares: 429,770,797
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.